Når først behandlingsmålet for den enkelte patient er opnået, bør dosis reduceres med 25- 50% for at fastholde hæmoglobin på det niveau.
82 Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level.